Survival of the Beautiful: Art, Science, and Evolution
David Rothenberg BloomSBury 256 pp. £14.99 (2011) The colour blue rules for the male satin bowerbird of Australia. The interior decorators of the avian world, they gather plastic, shells and feathers of that hue to adorn their meticulously built stick structures, all to lure a potential mate. This is just one indication, argues philosopher and musician David Rothenberg, that beauty is not random but is intrinsic to life -and that evolution proceeds by sumptuousness, not by utility alone. Rothenberg covers topics such as camouflage, abstraction, the profound impact of art on science and much more to explore his theme.
Drive and Curiosity: What Fuels the Passion for Science
Istvan Hargittai PrometheuS 338 pp. $26 (2011) What propels scientists towards great breakthroughs? Drive and curiosity are only part of it, argues Hungarian chemist Istvan Hargittai. Personality, motivation and accidents of circumstance led luminaries such as the co-discoverer of DNA structure James Watson, Nobel-prizewinning biochemist Gertrude Elion and theoretical physicist George Gamow to their big discoveries. The snapshot of Frederick Sanger -two-times Nobel prizewinner -is refreshing. The methodical biochemist's regard for doing a steady job, says Hargittai, helped to pave the way to the Human Genome Project.
Models. Behaving. Badly: Why Confusing Illusion with Reality Can Lead to Disaster, on Wall Street and in Life Emanuel Derman Free PreSS 240 pp. $26 (2011)
As a theoretical physicist and Wall Street analyst, Emanuel Derman has produced financial models that have become industry standards. But he has long warned that such models, however elegant, are inadequate: human behaviour must be factored in. Derman calls for financial models to be seen as "parallel thought universes" that should be taken with a kilogram of salt. Ranging wittily across philosophy, literature and the arcane world of high finance, Derman's argument is a heady mix of physics, economics and memoir.
neoconservatives' fundamental distrust of human nature, which underlies their belief that people cannot manage technological progress wisely. He makes much of the irony that neoconservatives associate science and technology with human commodification and alienation -the very problems once identified as the hallmarks of capitalism by Karl Marx. Furthermore, he shows that the neoconservative analysis is too shallow: progressives go farther by concluding that the social and economic backdrop to a technology is what determines its impact.
Moreno goes to some lengths to place his ideas in a larger philosophical context that extends from Socrates to Friedrich Nietzsche. In particular, he aims to demonstrate that a progressive, pro-science stance is consistent with the values of the eighteenth-century Enlightenment period that inspired the birth of the United States and the development of other Western democracies.
But Moreno's analysis focuses too heavily on the neoconservatives. He does not address why US Republicans do not object to the use of biotechnology in agriculture or pharmaceuticals, to nuclear power or to new computer and communications technologies. The 'neocon' label in US politics has changed in meaning since it was first coined, and it is now associated mainly with an interventionist foreign policy. Are the main figures from the Bush era -such as Leon Kass, who headed the President's Council on Bioethics from 2001 to 2005 -still influential? How many conservatives would applaud Kass's statement in his book Toward a More Natural Science (Free Press, 1985) : "Science -however much it contributes to health, wealth and safety -is neither in spirit nor in manner friendly to the … moral and civic education of human beings and citizens"?
Moreno frets that the political right wing, by investing in the human factor -such as reproduction -has the advantage in appealing to the public. He encourages the left to build on its concern for human rights and the redistribution of wealth, and to create a progressive biopolitics.
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